Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 38 of 38
SESSION OVERVIEW
Peter W Hunt
University of California San Francisco, San Francisco, CA, USA
Grace A McComsey
University Hospitals Cleveland Medical Center, Cleveland, OH, USA
Sadaf Farooqi
Cambridge University, Cambridge, United Kingdom
Jane O'Halloran
Washington University in St Louis, St Louis, MO, USA
Cissy M Kityo
Joint Clinical Research Centre, Lubowa, Uganda
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Wafaa M El-Sadr
Columbia University, New York, NY, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
THE ROLE OF CONTACT TRACING IN EPIDEMIC CONTROL: FACILITATORS AND BARRIERS
Chi-Chi N. Udeagu
New York City Department of Health and Mental Hygiene, Queens, NY, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
CONTACT TRACING FOR HIV AND SEXUALLY TRANSMITTED INFECTIONS
Matthew R Golden
University of Washington, Seattle, WA, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
CONTACT TRACING GOES VIRAL: VALUE AND ETHICS OF DIGITAL CONTACT TRACING
Jeffrey Kahn
Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
MODERATED DISCUSSION WITH QUESTIONS AND ANSWERS FROM THE AUDIENCE
Wafaa M El-Sadr
Columbia University, New York, NY, USA
Chi-Chi N. Udeagu
New York City Department of Health and Mental Hygiene, Queens, NY, USA
Matthew R Golden
University of Washington, Seattle, WA, USA
Jeffrey Kahn
Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Katharine J Bar
University of Pennsylvania, Philadelphia, PA, USA
John M Coffin
Tufts University, Medford, MA, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
HIV-1 ENV AND SARS-COV-2 SPIKE EVOLUTION: SIMILARITIES AND DIFFERENCES
Bette Korber
Los Alamos National Laboratory, Los Alamos, NM, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SARS-COV-2 EVOLUTION AT THE POPULATION LEVEL
Morgane Rolland
Walter Reed Army Institute of Research, Silver Spring, MD, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
STRUCTURE AND FUNCTION OF SARS-COV-2 SPIKE PROTEIN VARIANTS
Jeremy Luban
University of Massachusetts Medical School, Worcester, MA, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SELECTION OF NEUTRALIZATION RESISTANT SARS-COV-2 MUTANTS
Paul Bieniasz
The Rockefeller University, New York, NY, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
ANTIBODY IMMUNITY TO SARS-COV-2 501Y.V2 THROUGH VACCINATION AND INFECTION
Penny Moore
University of Witwatersrand, Johannesburg, South Africa
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
PANEL DISCUSSION
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Carlos del Rio
Emory University, Atlanta, GA, USA
Diane V Havlir
University of California San Francisco, San Francisco, CA, USA
Francois Venter
Ezintsha, Johannesburg, South Africa
Nittaya Phanuphak
Institute of HIV Research and Innovation, Bangkok, Thailand
Charles W Flexner
Johns Hopkins University, Baltimore, MD, USA
Hyman Scott
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Guido Silvestri
Emory University, Atlanta, GA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
HUMORAL RESPONSES AGAINST THE SARS-COV-2 SPIKE
Andrés Finzi
Université de Montréal, Montreal, Canada
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
T CELL IMMUNITY IN SARS-COV-2 NATURAL INFECTION AND FOLLOWING VACCINATION
Julie McElrath
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
LONGITUDINAL ANTIBODY RESPONSES TO SARS-COV-2 AND EMERGING VARIANTS
Katie J Doores
King's College London, London, United Kingdom
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
PROGRAMMING DURABLE IMMUNITY
Robert Seder
Vaccine Research Center, Bethesda, MD, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
PATHOLOGICAL B CELL ACTIVATION DURING SARS-COV-2 INFECTION
Ignacio Sanz
Emory University, Atlanta, GA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
SETTING THE STAGE: UNAIDS 2030 GOALS AND CURRENT STATE OF THE EPIDEMIC
Sheena McCormack
University College London, London, United Kingdom
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
CHALLENGES TO PREP SCALE-UP
Mark Dybul
Georgetown University, Washington, DC, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
PREP IMPLEMENTATION IN SUB-SAHARAN AFRICA
Elizabeth Irungu
Jomo Kenyatta University of Agriculture and Technology, NAIROBI, Kenya
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
INTERACTIVE DISCUSSION
Mark Dybul
Georgetown University, Washington, DC, USA
Sheena McCormack
University College London, London, United Kingdom
Elizabeth Irungu
Jomo Kenyatta University of Agriculture and Technology, NAIROBI, Kenya
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
WELCOME AND SESSION OVERVIEW
Roy M Gulick
Weill Cornell Medicine, New York, NY, USA
Karine Lacombe
Sorbonne Université, Paris, France
Paul E Sax
Brigham and Women's Hospital, Boston, MA, USA
Zarir F Udwadia
Hinduja Hospital and Medical Research Center, Mumbai, India
Claudia P. Cortes
University of Chile, Santiago, Chile
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
DISPARITIES IN COVID-19 AMONG RACIAL AND ETHNIC MINORITIES IN THE US
Mary T Bassett
Harvard T.H. Chan School of Public Health, Boston, MA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
DISPARITIES IN COVID-19 IN NATIVE AMERICAN COMMUNITIES
David R Wilson
National Institutes of Health, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
INCARCERATED POPULATIONS AND COVID-19
Robert E Fullilove
Columbia University Medical Center, New York, NY, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
MODERATED DISCUSSION
Mary T Bassett
Harvard T.H. Chan School of Public Health, Boston, MA, USA
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
Robert E Fullilove
Columbia University Medical Center, New York, NY, USA
David R Wilson
National Institutes of Health, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Nicolas Chomont
Université de Montréal, Montreal, Canada
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
PANEL DISCUSSION
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
SARS-COV-2 DEBRIS AND ITS CONTRIBUTION TO COVID-19
Benjamin tenOever
Icahn School of Medicine at Mount Sinai, New York, NY, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
TOWARD SWEET THERAPIES FOR SOUR IMMUNOPATHOLOGIES IN COVID-19
Catherine A Blish
Leland Stanford Junior University, Stanford, CA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
AFUCOSYLATED IGG RESPONSES AND SEVERITY IN COVID-19
Gestur Vidarsson
Sanquin Research/University of Amsterdam, Amsterdam, Netherlands
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
ANTICIPATING ESCAPE PATHWAYS FOR SARS-COV-2
Julie Overbaugh
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
THE SPECTRUM OF T CELL RESPONSES TO SARS-COV-2
Marcus Buggert
Karolinska Institutet, Huddinge, Sweden
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 38 of 38